Back to Rare Disease
This trial is complete. It is no longer accepting participants.

NCT00004685

NCT00004685
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with facioscapulohumeral muscular dystrophy (a specific type of muscle disease affecting the face, shoulders, and limbs)
  • You have weakness in the muscles of your face, such as around your eyes, forehead, or mouth
  • You have weakness in the muscles around your shoulder blades or in your foot/ankle that helps lift your foot
  • You have a certain level of arm weakness as measured by a standard scale (confirm with trial site)
  • You are between 18 and 80 years old
  • You are able to walk

Who may not be able to join:

  • You have another muscle or nerve disease that looks similar to facioscapulohumeral dystrophy, such as certain eyelid, eye movement, or muscle problems (confirm with trial site)
  • You have had long-term use of steroid tablets (more than 1 year total)
  • You have used steroid medicines in the last 3 months
  • You are currently taking medicines that suppress the immune system
  • You are currently taking certain medicines including stimulants, antidepressants, or beta-blockers (a type of heart/blood pressure medicine)
  • You are currently scheduled for or recovering from surgery
  • You have heart disease, high blood pressure, or blocked heart arteries
  • You are pregnant or breastfeeding
  • You have another serious medical or mental health condition that is not well controlled

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Ohio State University
Registry
clinicaltrials_gov
Start date
1 January 1998

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov